I-6 RISK STRATIFICATION FOR OA PROGRESSION
نویسندگان
چکیده
منابع مشابه
Biomarkers for Risk Stratification of Neoplastic Progression in Barrett Esophagus
Barrett esophagus (BE) is caused by chronic gastroesophageal reflux and predisposes to the development of esophageal adenocarcinoma through different grades of dysplasia. Only a subset of BE patients will finally develop esophageal adenocarcinoma. The majority will therefore not benefit from an endoscopic surveillance program, based on the histological identification of dysplasia. Several studi...
متن کاملKnee OA, biomechanics, and progression to TKA
Osteoarthritis (OA), the most prevalent type of arthritis, is characterized by damage to articular cartilage, a protective layer over the ends of bones, leading to changes in other joint structures (bones, ligaments, muscles, and nerves) that subsequently result in pain, stiffness, and functional disability in adults.1 OA is common at the knee joint, more so in the medial tibiofemoral compartme...
متن کاملRisk stratification with cardiac troponin I in acute coronary syndromes.
Recent years have shown a rapidly growing interest among clinical chemists, clinical cardiologists and emergency physicians in the use of new biochemical markers for risk stratification of patients with acute coronary syndrome (ACS). It was demonstrated across a wide range of ACS patient populations (including low-, intermediate-, and high-risk) that evidence of myocardial injury upon presentat...
متن کاملRisk stratification in acute coronary syndrome using cardiac troponin I.
The interest in risk stratification of patients with acute coronary syndrome (ACS), i.e., acute myocardial infarction (MI) and unstable angina pectoris (AP), has increased considerably within recent years because of improved knowledge of pathology, progress in immunoassays of already existing biochemical markers, introduction of new biochemical markers [especially cardiac troponin I (cTnI) and ...
متن کاملHigh-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population.
BACKGROUND Past investigations regarding the utility of high-sensitivity cardiac troponin I (cTnI) assays have been focused primarily on the acute coronary syndrome setting. We assessed whether such assays can predict future ischemic cardiovascular events in a stable high-risk population. METHODS We quantified serum cTnI using an investigational high-sensitivity assay (hs-cTnI IUO, Beckman Co...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Osteoarthritis and Cartilage
سال: 2008
ISSN: 1063-4584
DOI: 10.1016/s1063-4584(08)60016-3